1.1Motor driven roller pump
A stepper motor rotates rollers that compress a flexible tube connected to the drug reservoir. The controller calculates the delivered volume from the number of motor steps and the calibrated displacement per step.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A stepper motor rotates rollers that compress a flexible tube connected to the drug reservoir. The controller calculates the delivered volume from the number of motor steps and the calibrated displacement per step.
A motor turns a lead screw that advances a carriage against the syringe plunger. The controller converts the commanded volume to carriage travel using the syringe barrel area.
The clinician enters the result, its units, and the specimen collection time. The controller checks the units and elapsed time since collection before applying the configured dosage table.
A clinician programs successive infusion rates and interval durations before delivery. The controller reads elapsed time from a crystal oscillator and switches rates at the programmed interval boundaries.
The processor filters the sensor readings and displays a time trend. The clinician selects a volume and delivery duration, and the pump controller executes the entered settings.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
An osmotic pump draws water from a sealed drive-water compartment across a semipermeable membrane and compresses a flexible reservoir containing a dilute bicarbonate solution. A pH electrode sits in the aquarium return line upstream of the injection port. A controller averages the pH readings, calculates a buffer volume from the difference between the measured pH and the setpoint, and meters that volume through an electrically actuated outlet valve. The controller waits for the circulating water to mix before calculating another dose.
A piezoelectric diaphragm pump replaces the osmotic pump and connects a collapsible drug reservoir to the delivery line. Inlet and outlet check valves direct flow through the chamber as voltage pulses flex the diaphragm. The processor calculates a dose volume from patient sensor data and converts that volume to an actuation count using a calibration table indexed by outlet pressure. It measures outlet pressure before delivery and applies the calculated pulse count as a single delivery interval.
A flexible drug reservoir driven by an osmotic chamber feeds two parallel outlet branches, each with a capillary restrictor and an electrically actuated isolation valve. Under a bench condition of 20 kilopascals across the restrictors and a water surrogate at 25 °C, the branches are sized for 5 and 25 microliters per hour, respectively. The processor samples the physiological sensor every 30 seconds and allocates delivery over a 10-minute window, opening at most one branch at a time. It uses branch calibrations indexed by measured differential pressure to convert the requested volume into valve-open time.
An osmotic pump feeds a drug reservoir outlet through a metering valve and a check valve to a medication port in the venous return line of a hemodialysis circuit. A blood pressure sensor supplies patient data to the dose processor, and the dialysis controller supplies blood flow and circuit status over a wired connection. The dose processor calculates a delivery volume from the pressure trend and opens the metering valve when the circuit reports blood flow within the configured range. It suspends delivery during a blood pump pause or a circuit alarm and recalculates the pending volume from current sensor data when flow resumes.
A skin-mounted optical sensor provides pulse measurements, and an accelerometer in the same housing measures motion during each optical sampling window. The processor rejects pulse windows with excessive motion or inconsistent beat intervals and computes a rolling median from the accepted windows. It converts the difference between the median pulse rate and a stored setpoint to a bounded dose command for the outlet valve of the osmotic pump. If too few accepted windows remain within the configured time interval, the processor holds the valve closed until a fresh estimate is available.
An osmotic drive compresses a flexible drug bellows against a guided end plate, and a Hall-effect position sensor tracks a magnet fixed to that plate. The processor maps end-plate position to remaining drug volume using a table recorded during calibration and estimates discharged volume from the change between settled readings taken before and after delivery. It calculates the requested dose from patient sensor data and uses the measured discharge to update its estimate of flow through the outlet valve. For the next dose, it divides the requested volume by the updated flow estimate to set the valve-open time.
A semipermeable membrane admits water to a chamber containing an osmotic agent. The incoming water expands that chamber and advances a sealed piston that expels drug from the adjacent reservoir.
A finger clip directs red and infrared light through tissue onto a photodiode. The monitor samples the pulsatile component at each wavelength and uses their ratio to estimate arterial oxygen saturation.
A fluid filled catheter transmits arterial pressure to a diaphragm coupled to a strain gauge bridge. An amplifier conditions the bridge output, and the sensor interface samples the resulting waveform.
A microcontroller calculates a rolling median of valid sensor readings and selects a dosage from a table of measurement bands. It applies the configured dose ceiling and maximum change per update before sending the resulting command to the pump.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The existing insulin pump mainly includes a drug delivery device and a drug storage device, the drug delivery device is a driving part, and a driving device is used to squeeze the drug storage device to continuously squeeze insulin in the drug storage device into the user's subcutaneous skin.B · US 2023/0141293 A1 · ¶ 2
In one example, a wireless medical sensor may include physiological sensor circuitry, wireless transceiver circuitry, and control circuitry. The physiological sensor circuitry may be capable of obtaining a physiological measurement of a patient.A · US 10,206,570 B2 · abstract
The control terminal converts the drug delivery information to drug delivery instructions that a program in the controller can use, the drug delivery instructions mainly include drug delivery time and travel of a stepper motor that reflects the drug delivery dosage, and sends the instructions to the controller in a wireless way such as in an infrared or via Bluetooth.B · US 2023/0141293 A1 · ¶ 34
An empty cell means only that no passage was reproduced there.
However, the use of communication cables may limit the range of applications available, as the cables may become prohibitively expensive at long distances and may physically tether a patient to a monitoring device, thereby limiting the patient's range of motion.A · US 10,206,570 B2 · ¶ 3
Though wireless medical sensors may transmit information without need of a communication cable, many wireless medical sensors may employ large batteries that are cumbersome, uncomfortable to wear, and expensive.A · US 10,206,570 B2 · ¶ 3
Accordingly, it is necessary to have reasonable control over the bolus infusion of the insulin pump.B · US 2023/0141293 A1 · ¶ 3
In view of the above, the main objective of the present invention is to provide art insulin pump infusion control method, which can reasonably control bolus infusion.B · US 2023/0141293 A1 · ¶ 4
patent.fyi, US 2026/0355413 A1, claim 1, first published 2026-11-19T11:28:41-05:00, https://patent.fyi/US20260355413/, SHA-256 c01852f543517b42cf28d6db9c1a30a5a59729903f19187fdc04e04f3b5f89b2